Clinical Trials Logo

Clinical Trial Summary

Acute deterioration among hospitalised patient can result in serious adverse events like cardiac arrest, unexpected death or unanticipated intensive care unit (ICU) admission. Most events are preceeded by deteriorating vital signs, and potentially avoidable.

To detect and treat hospitalised at-risk patients early an early warning score (EWS) was introduced at the investigator site. EWS measures of a number of physiological parameters that are aggregated to a common score, that directs monitoring frequency, clinical interventions and competency of the provider.

Patients with low scores (0 - 1) are monitored every 12th hour and seldom experience serious adverse events. The optimal monitoring frequency for this group is unknown, and presently based on a compromise between patient safety and work load issues.

The aim of the present study is to explore if an 8 hourly monitoring interval (intervention) is correlated with a better outcome than 12 hour intervals (control), based on the number of patients that deteriorate to a higher EWS 24 hours after hospital admission in each group.


Clinical Trial Description

Acute deterioration among hospitalised patient can result in serious adverse events like cardiac arrest, unexpected death or unanticipated intensive care unit (ICU) admission. Most events are preceeded by deteriorating vital signs, and potentially avoidable.

To detect and treat hospitalised patients at risk of clinical deterioration in a timely manner, an early warning score (EWS) was introduced at the investigator site. EWS includes measures for respiratory rate, arterial hemoglobin oxygen saturation, pulse rate, systolic blood pressure, level of consciousness according to AVPU score, temperature, and whether a patient receives supplementary oxygen. Each vital sign can be assigned between 0 to 3 points (supplementary oxygen 0 or 2) depending on how much it deviates from a predefined threshold; the values are added to an aggregated score from 0 to 20, higher scores indicating more severe disease. An escalation protocol that directs the type of clinical response and competency of the provider according to EWS triggers was also introduced as an integrated part of the system.

Patients with low scores (0 - 1) are monitored every 12th hour and seldom experience serious adverse events. The optimal monitoring frequency for this group is unknown, and presently based on a compromise between patient safety and work load issues.

The aim of the present study is to explore if an 8 hourly monitoring interval (intervention) is correlated with a better outcome than 12 hour intervals (control) in the group of patients that have an EWS of 0 or 1 on admission. Deterioration is based on the number of patients that deteriorate to a higher EWS 24 hours after the first EWS is measured. Since serious adverse events in this population are rare the primary outcome is clinical deterioration defined as number of patients with elevated EWS >/= 2 in each group, 24 hours after admission to the hospital.

This is a cluster-randomized, non-blinded, pragmatic, interventional study of acutely admitted, adult patients to surgical or medical wards at our hospital. ;


Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02180854
Study type Interventional
Source Bispebjerg Hospital
Contact
Status Completed
Phase N/A
Start date September 2014
Completion date January 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01185756 - MIBG Scintigraphy as a Tool for Selecting Patients Requiring Implantable Cardioverter Defibrillator (ICD) N/A
Active, not recruiting NCT02933437 - The Response To Ajmaline Provocation in Healthy Subjects Phase 2
Recruiting NCT02920203 - Genetic Autopsy and Sudden Death N/A
Recruiting NCT02816047 - Austrian Wearable Cardioverter Defibrillator Registry
Completed NCT04918303 - Skin Sympathetic Nerve Activity and Cardiac Arrhythmia N/A
Recruiting NCT00469794 - The Significance of Arrhythmias in Athletes N/A
Completed NCT00692666 - Letigen® and Cardiovascular Morbidity Phase 4
Completed NCT02527031 - A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (APACAR2) N/A
Withdrawn NCT01422174 - Clinical Registry on Sudden Death Primary Prevention at Latin America N/A
Recruiting NCT00673842 - Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction Phase 3
Completed NCT01326624 - Study of the Wearable Defibrillator in Heart-Failure Patients N/A
Recruiting NCT01847378 - Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular Tachycardias N/A
Recruiting NCT00741728 - Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population N/A
Completed NCT01446965 - Vest Prevention of Early Sudden Death Trial and VEST Registry N/A
Recruiting NCT02685540 - Death Rate in Anesthesia: A Study in a Tertiary Hospital N/A
Recruiting NCT02732067 - Death Rate in Anesthesia, a Study in a Tertiary Hospital N/A
Completed NCT01804439 - Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes N/A
Completed NCT03320902 - Sudden Death Counselling and Its Impact on Family Members of Sudden Death Victims N/A
Recruiting NCT02874469 - Impact of an Intensive Care Diary on Post-traumatic Stress Disorder After a Resuscitated Sudden Death N/A
Completed NCT03111043 - Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors